Elsevier

Hepatology

Volume 22, Issue 5, November 1995, Pages 1447-1455
Hepatology

Other clinical study
Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma,☆☆

https://doi.org/10.1016/0270-9139(95)90151-5Get rights and content

Abstract

Our aim was to isolate potentially important differentially expressed gene products from paired human hepatocellular carcinoma (HCC) and normal liver samples using the differential messenger RNA (mRNA) display technique. Total RNA samples were reverse transcribed with anchoring oligonucleotide primers and then amplified by the polymerase chain reaction (PCR) with additional upstream random primers. Differentially expressed complementary DNA (cDNA) products were subsequently used as probes in Northern blot analysis. One such cDNA product, present in tumor but absent in normal displays, showed identity with the adhesion molecule integrin alpha 6. In Northern blots of 16 HCC pairs, the ∼5.5 kb signal of integrin alpha 6 mRNA was overexpressed in seven tumors, with a weak signal in the normal livers. For those patients with versus without integrin alpha 6 mRNA overexpression: (1) grade III (or IV) histology was noted in seven of seven versus three of nine tumors, respectively (P = .03); (2) tumor recurrence or death (at mean follow-up of 18 months) was noted in six of seven versus three of eight patients, respectively (P = .17). Similar results were obtained using semiquantitative PCR co-amplification with glyceraldehyde 3-phosphate dehydrogenase as a control; ∼50% of the tumors had stronger integrin alpha 6 bands than their paired normals. Both A and B variants of integrin alpha 6 mRNA were detectable in the tumor and normal liver samples. The B variant was more pronounced than the A variant by 8.9-fold in the tumors (n = 10) compared with threefold in the normal livers (n = 10), suggesting that the overexpression of integrin alpha 6 may be more reflective of abnormalities of B variant levels than of A variant levels. Important genes whose expression correlates with significant patient variables may be isolated by differential display; based on this small series there is a trend for integrin alpha 6 mRNA to be overexpressed in high-grade HCC and to predict a tendency toward a poorer outcome.

References (50)

  • PS Steeg et al.

    Evidence for a novel gene associated with lower tumor metastatic potential

    J Natl Cancer Inst

    (1990)
  • P Basset et al.

    A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

    Nature

    (1990)
  • C Schweinfest et al.

    Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas

  • P Liang et al.

    Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization

    Nucleic Acids Res

    (1993)
  • R Sager et al.

    Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene

    FASEB J

    (1993)
  • Z Zou et al.

    Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

    Science

    (1994)
  • K Okuda et al.

    Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas, proposal of new classification

    Cancer

    (1984)
  • ME Hemmler

    Structures and functions of VLA proteins and related integrins

    (1991)
  • MA Schwartz

    Signaling by integrins: implications for tumorigenesis

    Cancer Res

    (1993)
  • UH Frixen et al.

    E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

    J Cell Biol

    (1991)
  • S Dedhar et al.

    Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate cancer cells selected by in vitro invasion through reconstituted basement membrane

    Clin Exp Metastasis

    (1993)
  • HA Edmondson et al.

    Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

    Cancer

    (1954)
  • G Barnard et al.

    Increased expression of human acidic ribosomal phosphoprotein PO mRNA in carcinomas of colonic and hepatocellular origin

    Cancer Res

    (1992)
  • G Barnard et al.

    Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein mRNAs as colonic carcinoma

    Cancer Res

    (1993)
  • G Barnard et al.

    PCR product sequencing with [α-33P]-dATP and [α-32P]-dATP

    Biotechniques

    (1994)
  • Cited by (58)

    • Integrin α6 targeted positron emission tomography imaging of hepatocellular carcinoma in mouse models

      2019, Journal of Controlled Release
      Citation Excerpt :

      Integrin α6 promotes the migration, invasion and survival of tumor cells by activating the PI-3K/Akt and HIF-1 pathways [12,16]. Many groups provided evidences about integrin α6 overexpression in HCC [17–22] and the prognostic value of integrin α6 expression in HCC patients [16]. Knockout of integrin α6β1 expression reverses the transformed phenotype of HCC cells [21].

    • Chapter 9 - Hepatic Stellate Cells and Liver Cancer

      2015, Stellate Cells in Health and Disease
    • CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells

      2011, Gastroenterology
      Citation Excerpt :

      A P value of less than .05 was considered statistically significant. It previously has been reported that integrin α6 messenger RNA (mRNA) is overexpressed in high-grade HCC.22 Here, we aimed to determine the role of α6 in a larger series of HCC patients.

    View all citing articles on Scopus

    This study was supported by a grant from the American Liver Foundation, Cedar Grove, NJ, to G. F. Barnard.

    ☆☆

    Portions of this work were presented at the annual meetings of the American Association for the Study of Liver Diseases, Chicago, IL, November 1994, and published in abstract form.50

    View full text